Literature DB >> 28552144

Natural history of cerebral cavernous malformations.

Chibawanye Ene1, Anand Kaul1, Louis Kim2.   

Abstract

Cerebral cavernous malformations (CCM) are vascular abnormalities of the central nervous system with an incidence of 0.4-0.5% and an annual rate of hemorrhage ranging from 0.7% to 1%. Most lesions are located in the cerebral hemisphere but some occur in deeper locations such as the basal ganglia and pons. The most common symptoms during presentation are headache, seizures, and focal neurologic deficits. Surgery remains the most effective treatment modality for symptomatic CCM, while the management of incidental CCM remains controversial. Factors associated with increased risk of hemorrhage include being female and less than 40 years old. This finding, however, is not consistent in all natural history studies evaluated. During follow-up, the most important and consistent risk factor for rebleed was a prior hemorrhage. Here, we provide an indepth but concise review of the literature regarding the natural history of CCMs.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  brainstem; cavernous malformations; familial cavernoma; hemorrhage; microsurgery; natural history; pediatric; radiation therapy; rebleed; seizure

Mesh:

Year:  2017        PMID: 28552144     DOI: 10.1016/B978-0-444-63640-9.00021-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  [Intracranial vascular malformations].

Authors:  D F Vollherbst; M Bendszus; M A Möhlenbruch
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.

Authors:  Miguel Alejandro Lopez-Ramirez; Angela Pham; Romuald Girard; Tine Wyseure; Preston Hale; Atsuki Yamashita; Janne Koskimäki; Sean Polster; Laleh Saadat; Ignacio A Romero; Charles T Esmon; Frederic Lagarrigue; Issam A Awad; Laurent O Mosnier; Mark H Ginsberg
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

3.  Predictive variables for the presence of vascular malformations as the cause of basal ganglia hemorrhages.

Authors:  Nazife Dinc; Sae-Yeon Won; Nina Brawanski; Johanna Quick-Weller; Eva Herrmann; Volker Seifert; Gerhard Marquardt
Journal:  Neurosurg Rev       Date:  2018-10-17       Impact factor: 3.042

Review 4.  Building Blood Vessels-One Rho GTPase at a Time.

Authors:  Haley Rose Barlow; Ondine Cleaver
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

Review 5.  Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.

Authors:  Shuli Liang; Xing Fan; Feng Chen; Yonghong Liu; Binghui Qiu; Kai Zhang; Songtao Qi; Guojun Zhang; Jinfang Liu; Jianguo Zhang; Jun Wang; Xiu Wang; Ziyang Song; Guoming Luan; Xuejun Yang; Rongcai Jiang; Hua Zhang; Lei Wang; Yongping You; Kai Shu; Xiaojie Lu; Guoyi Gao; Bo Zhang; Jian Zhou; Hai Jin; Kaiwei Han; Yiming Li; Junji Wei; Kun Yang; Gan You; Hongming Ji; Yuwu Jiang; Yi Wang; Zhiguo Lin; Yan Li; Xuewu Liu; Jie Hu; Junming Zhu; Wenling Li; Yongxin Wang; Dezhi Kang; Hua Feng; Tinghong Liu; Xin Chen; Yawen Pan; Zhixiong Liu; Gang Li; Yunqian Li; Ming Ge; Xianming Fu; Yuping Wang; Dong Zhou; Shichuo Li; Tao Jiang; Lijun Hou; Zhen Hong
Journal:  Ther Adv Neurol Disord       Date:  2022-08-16       Impact factor: 6.430

Review 6.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.